1. Home
  2. XBIT vs EARN Comparison

XBIT vs EARN Comparison

Compare XBIT & EARN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.45

Market Cap

73.2M

Sector

Health Care

ML Signal

HOLD

EARN

Ellington Residential Mortgage REIT of Beneficial Interest

HOLD

Current Price

$5.34

Market Cap

189.7M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
XBIT
EARN
Founded
2005
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
73.2M
189.7M
IPO Year
2015
2013

Fundamental Metrics

Financial Performance
Metric
XBIT
EARN
Price
$2.45
$5.34
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$5.88
AVG Volume (30 Days)
60.5K
316.4K
Earning Date
11-12-2025
02-20-2026
Dividend Yield
N/A
18.18%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$35,893,000.00
Revenue This Year
N/A
$8.43
Revenue Next Year
N/A
$17.27
P/E Ratio
N/A
N/A
Revenue Growth
N/A
43.30
52 Week Low
$2.09
$4.33
52 Week High
$4.67
$6.86

Technical Indicators

Market Signals
Indicator
XBIT
EARN
Relative Strength Index (RSI) 50.59 55.40
Support Level $2.40 $5.15
Resistance Level $2.55 $5.35
Average True Range (ATR) 0.11 0.10
MACD 0.00 0.01
Stochastic Oscillator 28.00 80.00

Price Performance

Historical Comparison
XBIT
EARN

About XBIT XBiotech Inc.

XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times. The company primary investment objectives are to generate attractive current yields and risk-adjusted total returns for shareholders. It invest in multiple parts of the CLO capital structure, principally mezzanine debt and equity tranches. Rather than focusing only on short-term current yield, it select investments that it believe will provide a strong total return to drive a sustainable earnings stream over a long-term horizon.

Share on Social Networks: